Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) just unveiled an update.
Extrawell Pharmaceutical Holdings Limited announced its unaudited consolidated results for the six months ending September 30, 2025, revealing a decrease in total assets from HK$1,526,352,000 to HK$1,098,039,000. The company also reported a decline in equity attributable to owners from HK$1,334,542,000 to HK$892,643,000, indicating financial challenges that may impact its operations and market positioning.
The most recent analyst rating on (HK:0858) stock is a Hold with a HK$0.09 price target. To see the full list of analyst forecasts on Extrawell Pharmaceutical Holdings Limited stock, see the HK:0858 Stock Forecast page.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is involved in producing a range of healthcare products and has a market presence that spans various regions.
Average Trading Volume: 2,813,225
Technical Sentiment Signal: Hold
Current Market Cap: HK$206.6M
For a thorough assessment of 0858 stock, go to TipRanks’ Stock Analysis page.